Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1

This study was supported by the Swiss National Science Foundation No. 31-124861 to GS. Conflict of Interest Statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Supplementary Material The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2019.00414/full#supplementary-material References Chava, K. R., Tauseef, M., Sharma, T., and Mehta, D. (2012). Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression. Blood 119, 308–319. doi: 10.1182/blood-2011-02-339473 PubMed Abstract | CrossRef Full Text | Google Scholar Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720–3732. doi: 10.1182/blood-2010-07-273417 PubMed Abstract | CrossRef Full Text | Google Scholar Franscini, N., Bachli, E. B., Blau, N., Leikauf, M. S., Schaffner, A., and Schoedon, G. (2004). Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110, 2903–2909. doi: 10.1161/01.CIR.0000146344.49689.BB PubMed Abstract | CrossRef Full Text | Google Scholar Hwang, H. V., Tran, D. T., Rebuffatti, M. N., Li, C. S., and Knowlton, A. A. (2018). Investigation of quercetin and hyperoside ...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research